NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,777,000 | +8.4% | 282,600 | +7.4% | 0.05% | +3.8% |
| Q2 2023 | $26,545,000 | +14.4% | 263,165 | +4.4% | 0.05% | +2.0% |
| Q1 2023 | $23,199,000 | +3.8% | 252,049 | +2.3% | 0.05% | 0.0% |
| Q4 2022 | $22,351,000 | +20.3% | 246,439 | +0.9% | 0.05% | +2.0% |
| Q3 2022 | $18,578,000 | -9.8% | 244,239 | +0.3% | 0.05% | -5.7% |
| Q2 2022 | $20,589,000 | -21.8% | 243,625 | -18.8% | 0.05% | -10.2% |
| Q1 2022 | $26,331,000 | -1.2% | 300,142 | -2.0% | 0.06% | +1.7% |
| Q4 2021 | $26,658,000 | +5.9% | 306,193 | -0.8% | 0.06% | -13.4% |
| Q3 2021 | $25,184,000 | -11.5% | 308,525 | -1.1% | 0.07% | -18.3% |
| Q2 2021 | $28,464,000 | +11.6% | 311,865 | +4.3% | 0.08% | +1.2% |
| Q1 2021 | $25,500,000 | -5.0% | 299,131 | +5.6% | 0.08% | -27.7% |
| Q4 2020 | $26,831,000 | +27.1% | 283,189 | +16.4% | 0.11% | +9.8% |
| Q3 2020 | $21,103,000 | +11.0% | 243,255 | +11.5% | 0.10% | -1.9% |
| Q2 2020 | $19,020,000 | +5.5% | 218,102 | -0.6% | 0.10% | -11.1% |
| Q1 2020 | $18,030,000 | -14.6% | 219,413 | -1.5% | 0.12% | -6.4% |
| Q4 2019 | $21,123,000 | +11.3% | 222,670 | +2.1% | 0.12% | +21.4% |
| Q3 2019 | $18,973,000 | -2.8% | 218,131 | +2.1% | 0.10% | -11.2% |
| Q2 2019 | $19,525,000 | +4.0% | 213,595 | +9.4% | 0.12% | -7.2% |
| Q1 2019 | $18,770,000 | +11.7% | 195,182 | -0.3% | 0.12% | -3.1% |
| Q4 2018 | $16,799,000 | +2.9% | 195,742 | +3.3% | 0.13% | +9.3% |
| Q3 2018 | $16,319,000 | +11.1% | 189,425 | -2.4% | 0.12% | +2.6% |
| Q2 2018 | $14,694,000 | -8.8% | 194,156 | -2.7% | 0.12% | -14.8% |
| Q1 2018 | $16,113,000 | -12.1% | 199,495 | -8.7% | 0.14% | -10.0% |
| Q4 2017 | $18,334,000 | -16.2% | 218,449 | -14.4% | 0.15% | -19.8% |
| Q3 2017 | $21,868,000 | +2.1% | 255,057 | -0.5% | 0.19% | -2.6% |
| Q2 2017 | $21,411,000 | +13.4% | 256,371 | +0.6% | 0.19% | +6.1% |
| Q1 2017 | $18,888,000 | +5.4% | 254,866 | +3.4% | 0.18% | -7.2% |
| Q4 2016 | $17,928,000 | -13.1% | 246,379 | -5.7% | 0.20% | -18.4% |
| Q3 2016 | $20,638,000 | -1.2% | 261,229 | +3.2% | 0.24% | -9.5% |
| Q2 2016 | $20,883,000 | -6.1% | 253,220 | -17.5% | 0.26% | +261.6% |
| Q1 2016 | $22,247,000 | -13.0% | 306,999 | +3.3% | 0.07% | -76.0% |
| Q4 2015 | $25,563,000 | +2.2% | 297,186 | +9.5% | 0.30% | -8.2% |
| Q3 2015 | $25,001,000 | -9.5% | 271,460 | -3.3% | 0.33% | -25.3% |
| Q2 2015 | $27,616,000 | +2.1% | 280,854 | +2.4% | 0.44% | +9.9% |
| Q1 2015 | $27,055,000 | +7.2% | 274,372 | +0.7% | 0.40% | +4.4% |
| Q4 2014 | $25,243,000 | -0.3% | 272,427 | +1.3% | 0.39% | -9.8% |
| Q3 2014 | $25,316,000 | +7.7% | 268,945 | +3.7% | 0.43% | +4.9% |
| Q2 2014 | $23,496,000 | +9.5% | 259,425 | +2.8% | 0.41% | -2.6% |
| Q1 2014 | $21,463,000 | +55.0% | 252,450 | +46.5% | 0.42% | +47.0% |
| Q4 2013 | $13,849,000 | +9.3% | 172,298 | +4.3% | 0.28% | -10.1% |
| Q3 2013 | $12,673,000 | +8.8% | 165,208 | +1.5% | 0.32% | 0.0% |
| Q2 2013 | $11,643,000 | – | 162,805 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |